Postoperative obesity treatment for obese patients with hepatocellular carcinoma prevents hepatocarcinogenesis: Special reference with bacterial flora

Postoperative obesity treatment for obese patients with hepatocellular carcinoma prevents hepatocarcinogenesis: Special reference with bacterial flora - Clarification of hepatocarcinogenesis in obese patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038764

Enrollment

Registered

2020-01-01

Start date

2020-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese patients with hepatocellular carcinoma

Interventions

For obese patients who schedule hepatectomy for initial hepatocellular carcinoma Obesity treatment group: diet 25 Kcal/Kg/d for 6 months For obese patients who schedule hepatectomy for initial he

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) obese patients (BMI 30Kg/m2 or more) who schedule hepatectomy for initial hepatocellular carcinoma 2) Age of 20 years or older

Exclusion criteria

Exclusion criteria: 1) Patients with BMI <30Kg/m2 who schedule hepatectomy for initial hepatocellular carcinoma 2) Recurrence of hepatocellular carcinoma 3) Age <20 years old

Design outcomes

Primary

Measure	Time frame
Hepatocarcinogenesis within 2 years after hepatic resection	—

Secondary

Measure	Time frame
Bacterial flora Serum diamine oxidase Fecal IgA Hepatic fibrosis	—

Countries

Japan

Contacts

Public ContactTanaka Shogo

Osaka City University Department of Hepato-Biliary-Pancreatic Surgery

m8827074@msic.med.osaka-cu.ac.jp0666453841

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026